Opinion
Video
Author(s):
Experts on bladder cancer discuss exciting new agents and treatment strategies and where they can potentially fit into urothelial cancer treatment paradigms.
CAR T-Cell Therapies Extend Treatment-Free Intervals in Multiple Myeloma With Regular Toxicity Monitoring
Park and Grivas Expand on Treatment Updates in Bladder Cancer
Fox Chase Cancer Center’s Dr. Allision Aggon Receives Earth Angel Award From Breast Cancer Nonprofit Organization
Oncology Experts Preview Top Abstracts From the 2024 ASCO Annual Meeting
Long-Term IO-IO Data Contest the Role of Frontline TKIs in Advanced RCC
Cabozantinib Plus Atezolizumab Fails to Improve OS Over Subsequent Novel Hormonal Therapy in mCRPC
RVU120 Shows Early Promise in R/R Metastatic or Advanced Solid Tumors
The WEE1 Inhibitor APR-1051 Shows Early Safety and Tolerability in Advanced, Mutated Solid Tumors
TYRA-300 Is Safe, Generates Preliminary Antitumor Activity in FGFR3+ Metastatic Urothelial Cancer
Experts Highlight Noteworthy Research From the 2024 ESMO Congress